» Articles » PMID: 25157983

Hypoxia Inducible Factors in Liver Disease and Hepatocellular Carcinoma: Current Understanding and Future Directions

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 2014 Aug 27
PMID 25157983
Citations 100
Authors
Affiliations
Soon will be listed here.
Abstract

Hypoxia inducible transcription factors (HIFs) activate diverse pathways that regulate cellular metabolism, angiogenesis, proliferation, and migration, enabling a cell to respond to a low oxygen or hypoxic environment. HIFs are regulated by oxygen-dependent and independent signals including: mitochondrial dysfunction, reactive oxygen species, endoplasmic reticular stress, and viral infection. HIFs have been reported to play a role in the pathogenesis of liver disease of diverse aetiologies. This review explores the impact of HIFs on hepatocellular biology and inflammatory responses, highlighting the therapeutic potential of targeting HIFs for an array of liver pathologies.

Citing Articles

Research Progress of Liver Cancer Recurrence Based on Energy Metabolism of Liver Cancer Stem Cells.

Wu M, Wang H, Wu X, Zeng H, Miao M, Song Y J Hepatocell Carcinoma. 2025; 12:467-480.

PMID: 40061164 PMC: 11887506. DOI: 10.2147/JHC.S500638.


Central role of hypoxia-inducible factor-1α in metabolic reprogramming of cancer cells: A review.

Zhu B, Cheng L, Huang B, Liu R, Ren B Medicine (Baltimore). 2024; 103(44):e40273.

PMID: 39496001 PMC: 11537650. DOI: 10.1097/MD.0000000000040273.


Cell cycle inhibitors activate the hypoxia-induced DDX41/STING pathway to mediate antitumor immune response in liver cancer.

Wong P, Chan C, Xue H, Goh C, Cheu J, Tse A JCI Insight. 2024; 9(22).

PMID: 39388278 PMC: 11601891. DOI: 10.1172/jci.insight.170532.


Copper Isotope Evidence of Oxidative Stress-Induced Hepatic Breakdown and the Transition to Hepatocellular Carcinoma.

Telouk P, Plissonnier M, Merle P, Zoulim F, Fares N, Guilloreau P Gastro Hep Adv. 2024; 1(3):480-486.

PMID: 39131686 PMC: 11307693. DOI: 10.1016/j.gastha.2022.02.024.


SerpinB3: A Multifaceted Player in Health and Disease-Review and Future Perspectives.

Cagnin S, Pontisso P, Martini A Cancers (Basel). 2024; 16(14).

PMID: 39061218 PMC: 11274807. DOI: 10.3390/cancers16142579.